Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Ester doai
Patent
1992-12-08
1994-06-14
Gerstl, Robert
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Ester doai
A61K 31557
Patent
active
053211286
ABSTRACT:
This invention relates a method for topical treatment of glaucoma or ocular hypertension by administration of an effective intraocular pressure reducing amount of a prostaglandin derivative of PGA, PGB, PGE and PGF, in which the omega chain contains a ring structure. The invention further relates to compositions comprising said prostaglandin derivatives in an ophthalmologically compatible carrier.
REFERENCES:
patent: 3956284 (1976-05-01), Hess et al.
patent: 3962312 (1976-06-01), Hayashi et al.
patent: 4011262 (1977-03-01), Hess et al.
patent: 4116988 (1978-09-01), Nelson
patent: 4117119 (1978-09-01), Kurono et al.
patent: 4128713 (1978-12-01), Schneider
patent: 4131738 (1978-12-01), Smith
patent: 4599353 (1986-07-01), Bito
patent: 4820728 (1989-04-01), Collins et al.
patent: 4824857 (1989-04-01), Goh et al.
patent: 4883819 (1989-11-01), Bito
patent: 5001153 (1991-03-01), Ueno
patent: 5057621 (1991-10-01), Cooper et al.
patent: 5151444 (1992-09-01), Ueno et al.
Bill A (1975) "Blood Circulation and fluid dynamics in the eye", Physiol. Rew. 55:383-417.
Bito L. Z., Draga A., Blanco D. J., Camras C. B. (1983) "Long Term Maintenance of Reduced intraocular Pressure by Daily or Twice Daily Topical Application of Prostaglandins to Cat or Rhesus Monkey Eyes" Invest. Ophthalmol. Vis. Sci. 24:312-319.
Bito L. Z., Camras C. B., Gum G. G., and Resul B. (1989), "The Ocular Hypotensive Effects and Side Effects of Prostaglandins on the Eyes of Experimental Animals" Progress in Clinical and Biological Research 312 Ed. L. Z., Bito and Johan Stjerchantz, A. R. Liss, Inc., New York.
Burke et al., "Prostaglandin F.sub.2.alpha. Effects on Rabbit IOP Negatively Correlate with Classical PGF.sub.2.alpha. -Receptor Stimulation" Presented at ARVO annual meeting in Florida May 1-6, 1988.
Bundy, Chem. Abst. 90:16814d, 1979.
Camras C. B., Bito L. Z., (1981) Reduction of intraocular pressure in normal and glaucomatous primate (Aotus trivirgatus) eyes by topically applied prostaglandin F.sub.2.alpha.. "Curr Eye Res"1:205-209.
Camras, C. B., Podos S. M., Rosenthal J. S., Lee P. Y., Severin C. H., (1987a). Multiple dosing of prostaglandin F.sub.2.alpha. or epinephrine or cynomolgus monkey eyes. I. Aqueous humor dynamics. Invest Opthalmol Vis Sci 28:463-469.
Camras C. B., Bhuyan K. C., Podos S. M., Bhuyan D. K., Master R. W. P. (1987b)"Multiple Dosing of Prostaglandin F.sub.2.alpha. or epinephrine or cynomologus monkey eyes. II. Slitlamp biomicroscopy, aqueous humor analysis, and fluoroescein angiography." Invest. Opthalmol. Vis. Sci. 28:921-926.
Camras C. B., Siebold E. C., Lustgarten, J. S., Serle, J. B., Frisch S. C., Podos S. M., Bito L. Z., (1988) "Reduction of IOP by prostaglandin F.sub.2.alpha. -1-isopropyl ester topically applied in glaucoma patients", Opthalamology 95(Supply.) 129 . [This article is referenced in the specification, and was raised as prior art in an opposition to Australian patent application 625096, which is is related to the instant application. However, we have been unable to locate a copy of this article.]
Crawford K., Kaufman P. L., and True Gabel, B. A., (1987), "Pilocarpine antagonzies PGF.sub.2.alpha. -induced ocular hypotension: Evidence for enhancement of uveoscleral outflow of PGF.sub.2.alpha.. " Invest. Ophthalmol. Vis. Sci. (Supp.) ARVO Abstracts 11.
Crawford, K., and Kaufman, P. L., (1987) "Pilocarpine Antagonizes Prostaglandin F.sub.2.alpha. -Induced Ocular Hypotension in Monkeys" Arch. Ophthamology 105 1112.
Flach A. H., Elisason J. A., (1988). "Topical prostaglandin E.sub.2 effects on normal human intraocular pressure," J. Ocu. Pharmacol. 4:13-18.
Gabelt, B. and Kaufman, P. L., (1989)"Prostanglandin F.sub.2.alpha. Increases Uvelscleral Outflow in the Cynomologus Monkey", Exp. Eye Res. 49 389-402.
Giuffre G/ (1985). "The effect of prostaglandin F.sub.2.alpha. in the human eye." Graefes Arch Clin. Exp. Ophthalmol. 222:139-141.
Granstrom, E., (1975) "Metabolism of 17-Phenyl-18,19,20-Trinor-Prostaglandin F.sub.2.alpha. in the Cynomolgus Monkey and the Human Female", Prostaglandins 9:19-45.
Kaufman P. L., (1986). "Effects on intracamerally infused prostaglandins on outlfow facility in cynomolgus monkey eyes with intact or retrodisplaced ciliary muscle." Exp. Eye Res. 43:819-927.
Kerstetter J. R., Brubaker R. F., Wilson S. E., Kullerstrand L. J., (1988). "Prostaglandin F.sub.2.alpha. -1-isopropylester lower intraocular pressure without decreasing aqueous humor flow." Am. J. Ophthalmol. 105:30-34.
Kirk-Othmar "Encyclopedia of Chemical Technology", 3d Ed. Supplement vol. 711-752 (1984).
Lee, P-Y, Shae H, XZu L., Qu C-K (1988). "The effect of prostaglandin F.sub.2.alpha. on intraocular pressure in normotensive human subjects." Invest. Ophthalmol. Vis. Sci. 29:1474-1477.
Miller, "Biological Activities of 17-phenyl-18,19,20-trinorprostaglandins", Prostaglandins 9 9-18 (1975).
Nilsson S. F. E., Stjernschantz J., and Bill A (1987) "PGF.sub.2.alpha. increase uveoscleral outflow," Invest. Ophthalmol Vis. Sci. Suppl. 284.
Villumsen, J. Alm A (1989) "Prostaglandin F.sub.2.alpha. isopropylester eye drops. Effects in normal human eyes." Br. J. Ophthalmol. 73:419-426.
Yankee, Chem. Abst. 88:62048x, 1978.
Woodard et al., "Prostaglandin, F.sub.2.alpha. Effects on IOP Negatively Correlate with Clasical PGF.sub.2.alpha. -Receptor Stimulation" Presented in Eightly International Congress of Eye Research in San Francisco Sep. 4-8, 1988.
Woodward et al. (1989) "Prostaglandin F.sub.2.alpha. Effects on Intraocular Pressure Negatively Correlate with FP-Receptor Stimulation" Invest. Ophthal. 30 (8) 1838-1842.
Prostaglandin F.sub.2.alpha. Effects on Rabbit IOP Negatively Correlate with Classical PGF.sub.2.alpha. -Receptor Stimulation Presented at ARVO annual meeting on Florida May 1-6, 1988, by Burke et al.
Prostaglandin F.sub.2.alpha. -Effects on IOP Negatively Correlate with Classical PGF.sub.2.alpha. -Receptor Stimulation Presented in Eightly International Congress of Eye Research in San Francisco Sep. 4-8, 1988, by Woodward et al. (Burke is one of the inventors).
Prostaglandin F.sub.2.alpha. Effects on Intraocular Pressure Negatively Correlate with FP-Receptor Stimulation Published in Invest. Opthal. vol. 30 (8) (1989) 1838-1842 by Woodward et al. (Burke one of inventors).
Biological Activities of 17-phenyl-18, 19,20-trinoprostaglandins in Prostaglandins 9 )1975) 9-18 by Miller et al.
Camras C. B. Bito L. Z., and Eakins K. E., (1977): "Reduction of intraocular pressure by prostaglandins applied to the eyes of concious rabbits", Invest Opthalmol Vis. Sci., 16:1125.
Kerstetter J. R., Brubaker R. F., Wilson S. E. and Kullenstrand B. S. (1987): "Prostaglandin F2 alpha 1-isopropyl ester effects on aqueous humor dynamics in human subjects", Invest Ophthalmol Vis Sci Suppl, 28:266.
Kerstetter J. R., Brubaker R. F. Wilson S. E. and Kullerstrand L. (1988) "Prostaglandin F2.sub..alpha. -1-Isopropylester Lowers Intracolor Pressure Without Decreasing Aqueous Humor Flow", Am. J. Ophthalmology 105:30-34.
Bito, Baroody and Miranda (1987); Eicosanoids as a new class of occular Hypotensive agents. The apparent therapeutic advantage of derived Prostaglandins of the A and B type as compared with primary protaglandins of the E, F and D types", Experimental Eye Research, 44:825.
Starr, M. S. (1971) "Further studies on the effect of prostaglandin on intraocular pressure in the rabit, Exp. Eye, Res. 11:170.
Kass, M. A., Posos, S. M., Moses, R. A., and Becker B. (1972): Prostaglandin E1 and aqueous humor dynamics", Invest Ophthalmol, 11:1022.
Vilumsen J. and Alm A. (1987): "The effect of prostaglandin F2.sub..alpha. eye drops in open angle glaucoma", Invest Opthalmol. Vis. Sci. 28:378.
Wang R-F. Cmanras C. B., Lee P-Y, Podos S. M. and Bito L. Z. (1987) "The ocular hypotensive effects of Prostaglandins F2.sub..alpha. isopropyl ester and A2 in glautomatous monkeys Invest Ophthalmol Vis Sci ARVO Supl. 28:266.
Kass M. A. Mandell A1, Goldberg I, Paine J. M. and Becker B (1979) "Dipivefrin and epinephrine treatment of elevated intraocular pressure; A comparative study", Arch Ophthalmol. 97:1865.
Goldberg I., Kolker A. E.
Resul Bahram
Stjernschantz Johan W.
Gerstl Robert
Kabi Pharmacia AB
LandOfFree
Prostaglandin derivatives for the treatment of glaucoma or ocula does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Prostaglandin derivatives for the treatment of glaucoma or ocula, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Prostaglandin derivatives for the treatment of glaucoma or ocula will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1250217